Current:Home > InvestHackers hit Rhode Island benefits system in major cyberattack. Personal data could be released soon -AssetTrainer
Hackers hit Rhode Island benefits system in major cyberattack. Personal data could be released soon
View
Date:2025-04-13 11:09:37
PROVIDENCE, R.I. (AP) — Cybercriminals could release personal data of many Rhode Islanders as early as this upcoming week in a major cyberattack that hit the state’s online system for delivering health and human services benefits, Gov. Daniel McKee said.
The hackers are demanding a ransom, officials said without elaborating.
The state urged Rhode Islanders to take action to protect their personal information, which may include names, addresses, dates of birth, Social Security numbers and certain banking information.
Anyone who has been involved in Medicaid, the Supplemental Nutrition Assistance Program known as SNAP, Temporary Assistance for Needy Families, Childcare Assistance Program, Rhode Island Works, Long-term Services and Supports and health insurance purchased through HealthSource RI may be impacted, McKee said Saturday.
The system known as RIBridges was taken offline on Friday, after the state was informed by its vendor, Deloitte, that there was a major security threat to the system. The vendor confirmed that “there is a high probability that a cybercriminal has obtained files with personally identifiable information from RIBridges,” the state said.
The state has contracted with Experian to run a toll-free hotline for Rhode Islanders to call to get information about the breach and how they can protect their data.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
veryGood! (211)
Related
- South Korea's acting president moves to reassure allies, calm markets after Yoon impeachment
- 'Saving lives': Maui police release dramatic body cam video of Lahaina wildfire rescues
- See Heidi Montag and Spencer Pratt’s Incredible Halloween Costume With Sons Gunner and Ryker
- With James Harden watching, Clippers take control in 3rd quarter to beat Magic 118-102
- Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
- Are real estate agent fees a racket?
- What 10 states are struggling the most to hire workers? See map.
- Oxford High School 2021 shooting was 'avoidable' if district followed policy, investigation says
- Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
- 2034 World Cup should never go to Saudi Arabia. But FIFA turns a blind eye to sports washing
Ranking
- The Louvre will be renovated and the 'Mona Lisa' will have her own room
- Adam Johnson Tragedy: Authorities Investigating Ice Hockey Player's Death
- As transgender health care draws patients to New Mexico, waitlists grow
- Robert De Niro tells jury that emotional abuse claims by ex-assistant are nonsense
- 2 killed, 3 injured in shooting at makeshift club in Houston
- Bangladesh launches new India-assisted rail projects and thermal power unit amid opposition protests
- Halloween 2023: The special meaning behind teal, purple and blue pumpkins
- Woman buys scratch-off ticket for first time, wins top prize from Kentucky lottery
Recommendation
Nearly 400 USAID contract employees laid off in wake of Trump's 'stop work' order
France vows a ‘merciless fight’ against antisemitism after anti-Jewish graffiti is found in Paris
North Dakota woman accused of fatally poisoning her boyfriend hours after he received an inheritance
Hate crime charges filed in death of Sikh man after New York City fender bender
Juan Soto to be introduced by Mets at Citi Field after striking record $765 million, 15
Eerie new NASA image shows ghostly cosmic hand 16,000 light-years from Earth
Sentencing postponed for Mississippi police officers who tortured 2 Black men
Potential cure for sickle cell disease raises few concerns for FDA panel